Item Type | Name |
Concept
|
Radiotherapy
|
Concept
|
Radiotherapy Dosage
|
Concept
|
Radiotherapy Planning, Computer-Assisted
|
Concept
|
Radiotherapy, Computer-Assisted
|
Concept
|
Radiotherapy, Adjuvant
|
Concept
|
Radiotherapy, Conformal
|
Concept
|
Radiotherapy, Intensity-Modulated
|
Concept
|
Radiotherapy, Image-Guided
|
Academic Article
|
Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.
|
Academic Article
|
A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation.
|
Academic Article
|
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
|
Academic Article
|
Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators.
|
Academic Article
|
Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts.
|
Academic Article
|
Evaluation of nuclear factor ?B and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610.
|
Academic Article
|
Reliability of EUCLIDIAN: an autonomous robotic system for image-guided prostate brachytherapy.
|
Academic Article
|
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
|
Academic Article
|
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
|
Academic Article
|
In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?).
|
Academic Article
|
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.
|
Academic Article
|
Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling.
|
Academic Article
|
Post-prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT.
|
Academic Article
|
Postprostatectomy radiation therapy: an evidence-based review.
|
Academic Article
|
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.
|
Academic Article
|
The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.
|
Academic Article
|
Characterization and outcomes of optic nerve gliomas: a population-based analysis.
|
Academic Article
|
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.
|
Academic Article
|
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.
|
Academic Article
|
The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
|
Academic Article
|
Radiotherapy improves survival in unresected stage I-III bronchoalveolar carcinoma.
|
Academic Article
|
Quality assurance peer review chart rounds in 2011: a survey of academic institutions in the United States.
|
Academic Article
|
A novel curvilinear approach for prostate seed implantation.
|
Academic Article
|
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
|
Academic Article
|
Implanted dosimeters identify radiation overdoses during IMRT for prostate cancer.
|
Academic Article
|
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
|
Academic Article
|
Late toxicity rates following definitive radiotherapy for prostate cancer.
|
Academic Article
|
Salvage radiotherapy for prostate cancer: Finding a way forward using radiobiological modeling.
|
Academic Article
|
Biomarkers of aging and radiation therapy tailored to the elderly: future of the field.
|
Academic Article
|
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients.
|
Academic Article
|
On the merits and limitations of whole-brain radiation therapy.
|
Academic Article
|
Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?
|
Academic Article
|
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.
|
Academic Article
|
Nutrient restriction and radiation therapy for cancer treatment: when less is more.
|
Academic Article
|
Systematic review of hypofractionated radiation therapy for prostate cancer.
|
Academic Article
|
Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials.
|
Academic Article
|
Commissioning and implementation of an implantable dosimeter for radiation therapy.
|
Academic Article
|
Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.
|
Academic Article
|
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.
|
Academic Article
|
Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
|
Academic Article
|
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy.
|
Academic Article
|
Probability of late rectal morbidity in 125I prostate brachytherapy.
|
Academic Article
|
Targeting angiogenic processes by combination low-dose paclitaxel and radiation therapy.
|
Academic Article
|
COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting.
|
Academic Article
|
Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?
|
Academic Article
|
A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.
|
Academic Article
|
Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways.
|
Academic Article
|
Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base.
|
Academic Article
|
Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trials.
|
Academic Article
|
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
|
Academic Article
|
VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
|
Academic Article
|
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
|
Academic Article
|
Hypoxia in prostate cancer: observation to intervention.
|
Academic Article
|
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.
|
Academic Article
|
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
|
Academic Article
|
Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy.
|
Academic Article
|
Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
|
Academic Article
|
Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.
|
Academic Article
|
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
|
Academic Article
|
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
|
Academic Article
|
Combination of vandetanib, radiotherapy, and irinotecan in the LoVo human colorectal cancer xenograft model.
|
Academic Article
|
Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
|
Academic Article
|
Evolution of advanced technologies in prostate cancer radiotherapy.
|
Academic Article
|
Phase I trials involving radiation therapy, quantifying the risks.
|
Academic Article
|
Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.
|
Academic Article
|
Potential for dose escalation in the postprostatectomy setting with intensity-modulated radiation therapy: a dosimetric study using EORTC consensus guidelines for target volume contours.
|
Academic Article
|
Radiation therapy and the immune system: learning to live together.
|
Academic Article
|
Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.
|
Academic Article
|
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
|
Academic Article
|
Combining targeted agents with modern radiotherapy in soft tissue sarcomas.
|
Academic Article
|
Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes.
|
Academic Article
|
Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
|
Academic Article
|
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.
|
Academic Article
|
Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the regione emilia-romagna, Italy.
|
Academic Article
|
Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data.
|
Academic Article
|
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.
|
Academic Article
|
The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer.
|
Academic Article
|
Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
|
Academic Article
|
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
|
Academic Article
|
Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.
|
Grant
|
Microenvironmental Control of the Radiation Response
|
Academic Article
|
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial.
|
Academic Article
|
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.
|
Academic Article
|
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.
|
Academic Article
|
Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.
|
Academic Article
|
Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer.
|
Academic Article
|
Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery.
|
Academic Article
|
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
|
Academic Article
|
Spine Stereotactic Body Radiation Therapy Residual Setup Errors and Intra-Fraction Motion Using the Stereotactic X-Ray Image Guidance Verification System.
|
Academic Article
|
Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer.
|
Academic Article
|
Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
|
Academic Article
|
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
|
Academic Article
|
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
|
Academic Article
|
A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.
|
Academic Article
|
Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy.
|